DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

PHARMACYCLICS, INC. (NASDAQ: PCYC)

256.59 -0.51 (-0.20%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PCYC $256.59 -0.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $257.50
Previous Close $257.10
Daily Range $256.35 - $257.67
52-Week Range $82.51 - $260.47
Market Cap $19.7B
P/E Ratio 233.73
Dividend (Yield) $0.00 (0.0%)
Volume 615,134
Average Daily Volume 973,324
Current FY EPS $0.26

Sector

Healthcare

Industry

Drug Makers

PHARMACYCLICS, INC. (PCYC) Description

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases. Website: http://www.pharmacyclics.com/

News & Commentary Rss Feed

Humira Propels AbbVie Inc. to a Solid First Quarter

AbbVie beats expectations on the strength of Humira, with help from new hep C drug Viekira Pak.

AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board

AbbVie Beats Earnings on Humira and HCV Sales, Ups View - Analyst Blog

Notable ETF Inflow Detected - FBT, ICPT, PCYC, CLDX

Gilead Sciences Vs. AbbVie: Which Is A Better Buy?

Pharmacyclics Announces Positive Results on Imbruvica - Analyst Blog

Is AbbVie (ABBV) Set to Top 1Q Earnings on Humira & HCV? - Analyst Blog

Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent

Johnson & Johnson's Earnings: What You Need to Know

Here’s what Johnson & Johnson’s quarterly earnings call means to investors like you.

Johnson & Johnson's Earnings: The Good, The Bad and The Ugly

Johnson & Johnson reported a mixed first-quarter this week. Here is what investors need to know going forward.

See More PCYC News...

PCYC's Top Competitors

PCYC $256.59 (-0.20%)
Current stock: PCYC
AMGN $167.91 (-0.74%)
Current stock: AMGN
BIIB $401.71 (-6.64%)
Current stock: BIIB
CELG $118.71 (2.26%)
Current stock: CELG